PAPPA2 as a Therapeutic Modulator of IGF-I Bioavailability: in Vivo and in Vitro Evidence.

about

PAPPA2 as a Therapeutic Modulator of IGF-I Bioavailability: in Vivo and in Vitro Evidence.

Item

http://www.wikidata.org/entity/Q55261233

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

PAPPA2 as a Therapeutic Modula ...... in Vivo and in Vitro Evidence.

@en

PAPPA2 as a Therapeutic Modula ...... in Vivo and in Vitro Evidence.

@nl

type

Item

label

PAPPA2 as a Therapeutic Modula ...... in Vivo and in Vitro Evidence.

@en

PAPPA2 as a Therapeutic Modula ...... in Vivo and in Vitro Evidence.

@nl

prefLabel

PAPPA2 as a Therapeutic Modula ...... in Vivo and in Vitro Evidence.

@en

PAPPA2 as a Therapeutic Modula ...... in Vivo and in Vitro Evidence.

@nl

P1476

PAPPA2 as a Therapeutic Modulator of IGF-I Bioavailability: in Vivo and in Vitro Evidence

@en

P2093

Andrew Dauber

http://www.w3.org/2001/XMLSchema#string

Jane Khoury

http://www.w3.org/2001/XMLSchema#string

Lihong Liao

http://www.w3.org/2001/XMLSchema#string

Melissa Andrew

http://www.w3.org/2001/XMLSchema#string

Vivian Hwa

http://www.w3.org/2001/XMLSchema#string

P2860

Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase

Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit

Hundreds of variants clustered in genomic loci and biological pathways affect human height

The insulin-like growth factor-binding protein (IGFBP) superfamily

Insulin-like growth factors and their binding proteins: biological actions

Rare and low-frequency coding variants alter human adult height

The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system.

Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis.

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature.

Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.

P304

646-656

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JS.2018-00106

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Masanobu Fujimoto

P577

2018-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29942928

http://www.w3.org/2001/XMLSchema#string

P932

6009608

http://www.w3.org/2001/XMLSchema#string